Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs

JAMA Internal Medicine

Volumn 174, Issue 12, 2014, Pages 1930-1933

  Moore, Thomas J ^a,b   Glenmullen, Joseph ^c   Mattison, Donald R ^d  

^a INSTITUTE FOR SAFE MEDICATION PRACTICES   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; APOMORPHINE; ARIPIPRAZOLE; BROMOCRIPTINE; CABERGOLINE; DOPAMINE; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; NEUROLEPTIC AGENT; PRAMIPEXOLE; ROPINIROLE; ROTIGOTINE; BENZOTHIAZOLE DERIVATIVE; INDOLE DERIVATIVE; PIPERAZINE DERIVATIVE; QUINOLONE DERIVATIVE;

ADULT; ARTICLE; COMPULSION; COMPULSIVE SHOPPING; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; HYPERPROLACTINEMIA; HYPERSEXUALITY; IMPULSE CONTROL DISORDER; MAJOR CLINICAL STUDY; MALE; MEDICAL DICTIONARY FOR REGULATORY ACTIVITIES; OUTCOME ASSESSMENT; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; RESTLESS LEGS SYNDROME; RETROSPECTIVE STUDY; RISK ASSESSMENT; SHOPPING; TREATMENT RESPONSE; UNITED STATES; AGED; AGONISTS; CHEMICALLY INDUCED; CONSUMER ATTITUDE; DRUG EFFECTS; DRUG LABELING; GAMBLING; IMPULSIVENESS; MIDDLE AGED; SEXUAL BEHAVIOR;

ADULT; AGED; BENZOTHIAZOLES; COMPULSIVE BEHAVIOR; CONSUMER BEHAVIOR; DOPAMINE AGONISTS; DRUG LABELING; FEMALE; GAMBLING; HUMANS; HYPERPROLACTINEMIA; IMPULSIVE BEHAVIOR; INDOLES; MALE; MIDDLE AGED; PARKINSON DISEASE; PIPERAZINES; QUINOLONES; RECEPTORS, DOPAMINE D3; RESTLESS LEGS SYNDROME; RETROSPECTIVE STUDIES; SEXUAL BEHAVIOR; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84919499802     PISSN: 21686106     EISSN: 21686114     Source Type: Journal    
DOI: 10.1001/jamainternmed.2014.5262     Document Type: Article

References (13)

1. Kelley BJ, Duker AP, Chiu P. Dopamine agonists and pathologic behaviors. Parkinsons Dis. 2012;2012:603631. doi:10.1155/2012/603631.
2. Weiss HD, Marsh L. Impulse control disorders and compulsive behaviors associated with dopaminergic therapies in Parkinson disease. Neurol Clin Pract. 2012;2(4):267-274. doi:10.1212/CPJ.0b013e318278be9b.
3. Cornelius JR, Tippmann-Peikert M, Slocumb NL, Frerichs CF, Silber MH. Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study. Sleep. 2010;33(1):81-87.
4. Tippmann-Peikert M, Park JG, Boeve BF, Shepard JW, Silber MH. Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists. Neurology. 2007;68(4):301-303. doi:10.1212/01.wnl.0000252368.25106.b6.
5. Voon V, Hassan K, Zurowski M, et al. Prospective prevalence of pathologic gambling and medication association in Parkinson disease. Neurology. 2006;66(11):1750-1752. doi:10.1212/01.wnl.0000218206.20920.4d.
6. Bancos I, Nannenga MR, Bostwick JM, Silber MH, Erickson D, Nippoldt TB. Impulse control disorders in patients with dopamine agonist-treated prolactinomas and nonfunctioning pituitary adenomas: a case-control study. Clin Endocrinol (Oxf). 2014;80(6):863-868doi:10.1111/cen.12375.
7. National Prescription Audit for 2012. Plymouth Meeting, PA: IMS Health Inc; 2012.
8. Weiss HD, Hirsch ES, Williams JR, Swearengin L, Marsh L. Detection of impulse control disorders in Parkinson disease patients. Neurologist. 2010;16(6):406-407. doi:10.1097/NRL.0b013e3181e8868b.
9. Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for Industry: Postmarketing Safety Reporting for Human Drug and Biological Products Including Vaccines. (Draft Guidance). http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Vaccines/ucm092257.pdf. Published 2001. Accessed September 4, 2014.
10. MedDRA MSSO. Introductory Guide MedDRA Version 16.1. Chantilly, VA: MedDRA Maintenance and Support Services Organization; 2013.
11. Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf. 2001;10(6):483-486. doi:10.1002/pds.677.
12. Newman AH, Blaylock BL, Nader MA, Bergman J, Sibley DR, Skolnick P. Medication discovery for addiction: translating the dopamine D3 receptor hypothesis. Biochem Pharmacol. 2012;84(7):882-890. doi:10.1016/j.bcp.2012.06.023.
13. Moore TJ, Bennett CL. Underreporting of hemorrhagic and thrombotic complications of pharmaceuticals to the U.S. Food and Drug Administration: empirical findings for warfarin, clopidogrel, ticlopidine, and thalidomide from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost. 2012;38(8):905-907. doi:10.1055/s-0032-1328890.